Onder Alpdogan

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Bradley M Haverkos, Onder Alpdogan, Robert A Baiocchi, Jonathan E Brammer, Tatyana Feldman, Marcelo Capra, Elizabeth A Brem, Santosh Nair, Phillip Scheinberg, Juliana Pereira, Leyla Shune, Erel Joffe, Patricia Young, Susan E Spruill, Afton Katkov, Robert McRae, Ivor Royston, Douglas V Faller, Lisa Rojkjaer, Pierluigi Porcu
Targeted therapy with nanatinostat and valganciclovir in recurrent Epstein-Barr virus-positive lymphoid malignancies: a Phase 1b/2 study. Blood advances (2023)
Kerry Joane Savage, Steven M Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Judith Trotman, Onder Alpdogan, Cheolwon Suh, Kensei Tobinai, Andrei Shustov, Marek Trněný, Sam Yuen, Pier Luigi Luigi Zinzani, Lorenz Trümper, Tim Ilidge, Owen A O'Connor, Barbara Pro, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Swaminathan Iyer
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2. Blood advances 6 (19) (2022)

Onder Alpdogan.css-eqlu8i{font-size:small;padding-left:4px;}